Buisness Development with Ionian
Ionian is focused on leveraging its rapid isothermal assay technology for the detection of DNA and RNA in many areas, including:
- Clinical point-of-care diagnostics
- Currently in development is rapid point of care (POC) assays for:
- Chlamydia & Gonorrhea
- - Influenza A & B
- - Tuberculosis
- - Other Infectious Pathogens
- Agriculture and crop testing (GMO)
Currently in development is rapid point of use assay detection systems for the GMO arena, where there are demanding requirements for detecting specific sequences in genetically modified crops.
- Veterinary applications
- Food safety
- Pathogen surveillance
- Research tool market
microRNAs: These 21-25 nucleotide small RNAs involved in numerous critical cell processes and cancer are ideally suited for amplification by the NEAR Assay.